Genome-wide CRISPR screen for PARKIN regulators reveals transcriptional repression as a determinant of mitophagy
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Significance: In mitophagy, damaged mitochondria are targeted for disposal by the autophagy machinery. PARKIN promotes signaling of mitochondrial damage to the autophagy machinery for engagement, and PARKIN mutations cause Parkinson’s disease, possibly because damaged mitochondria accumulate in neurons. Because regulation of PARKIN abundance and the impact on signaling are poorly understood, we performed a genetic screen to identify PARKIN abundance regulators. Both positive and negative regulators were identified and will help us to further understand mitophagy and Parkinson’s disease. We show that some of the identified genes negatively regulate PARKIN gene expression, which impacts signaling of mitochondrial damage in mitophagy. This link between transcriptional repression and mitophagy is also apparent in neurons in culture, bearing implications for disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig. 4. THAP11 is part of a functional gene network mediating transcriptional repression of endogenous PARKIN in JumpIN cells. (A) THAP11, HCFC1, and OGT negatively regulate PARK2 mRNA level. PARK2 mRNA level relative to HPRT1 was determined by qPCR on total RNA extracted from stable cell pools of parental JumpIN cells expressing nontargeting (SCR), THAP11- (second strongest sgRNA from screen), HCFC1-, or OGT-specific sgRNAs (strongest sgRNA in screen); n = 3; error bars indicate SDs. **P < 0.01, ***P < 0.001. Average CRISPR/Cas9 editing efficiencies were assessed by TIDE. (B) Targeting of either OGT (Left) or THAP11 (Right) negatively affects endogenous PARKIN protein level. Stable pools of parental cells as in A were analyzed by WB using antibodies indicated. *Nonspecific cross-reaction. CRISPR/Cas9 editing efficiencies were assessed by TIDE. (C and D) Parental cells were infected with THAP11-specific (second strongest sgRNA in screen) or SCR sgRNAs in triplicates for 15 d. Cell extracts were subjected to RNAseq (C), qPCR (D), or WB to assess THAP11 depletion and PARKIN protein elevation (Fig. S4B). In C, transcript fold-changes of THAP11-targeted vs. SCR samples (x-axis, log2) were plotted against P values (y axis, −log10). For hit calling, thresholds were set to <−1 and >1 log2 fold-changes and P < 0.01. The 10 genes most strongly repressed are labeled in blue. PACRG is also repressed by THAP11 (green). (D) qPCR using Taqman probes indicated, scored relative to GAPDH or HPRT1 (PACRG) mRNA, normalized to SCR control. n = 3; error bars indicate SDs. **P < 0.01, ***P < 0.001. (E) Gene-set enrichment analysis suggests modulation of diverse biological processes upon THAP11 depletion. Enrichment analysis for RNAseq using a weighted one-sided Kolmogorov-Smirnov test; test statistic D and negative logarithm (base 10) of adjusted P values are reported. The 10 most enriched sets among up-regulated (Upper) or down-regulated (Lower) transcripts are shown. (F) Comparison of the RNAseq dataset from THAP11-depleted JumpIN cells with data from Poché et al. (29), showing numbers of transcripts regulated by THAP11 in either one or both experiments [cutoff <−1 and >1 fold-changes (log2); P < 0.01]; genes commonly regulated by THAP11 are listed. eff., efficiency; fc, fold-change; ref., reference transcript; rel., relative; WB, Western blot.](https://figures.cochat.ai/paper-figures/ae61383deef5445eae5b9c3c20d12b6d/genome-wide-crispr-screen-for-parkin-regulators-reveals-transcriptional-figure-4.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Recently, we implemented large-scale CRISPR-based genetic screens for the first time in a human iPSC-derived differentiated cell type, namely neurons76.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [76]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Third, an arrayed longitudinal imaging screens uncovered consequences of gene knockdown for neuron-specific morphological features, such as neurite length and branching patterns76, which could not have been evaluated in other cell types.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [76]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Second, housekeeping genes that were essential for survival of both iPSCs and neurons may play different roles in the two cell types, based on vastly different transcriptomic consequences of their knockdown76.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [76]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“CRISPR screening recovered a previously known key regulator of neuronal cell death, MAP3K12/DLK76.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [76]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“First, the set of genes controlling survival of neurons were distinct from those controlling cancer cell or iPSC survival.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [76]
Experimental — accuracy not yet measured
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
MEME SUITE: tools for motif discovery and searching
Bailey, T. L., Boden, M., Buske, F. A., Frith, M., Grant, C. E., Clementi, L., Ren, J., Li, W. W., & Noble, W. S. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp335 · Cited by 10,648
STRING v10: protein–protein interaction networks, integrated over the tree of life
Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., Simonovic, M., Roth, A., Santos, A., Tsafou, K. P., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1003 · Cited by 10,436
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 2×
“Mutations in both PINK1 and PARKIN are a cause of familial Parkinson’s disease, suggesting that compromised mitophagy is an underlying feature (10, 11).”
BackgroundPruitt, K. D., Tatusova, T., & Maglott, D. R. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl842 · Cited by 4,481
Super-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856
Cited by
A brief history of human disease genetics
Claussnitzer, M., Cho, J. H., Collins, R., Cox, N. J., Dermitzakis, E. T., Hurles, M. E., Kathiresan, S., Kenny, E. E., Lindgren, C. M., MacArthur, D. G., et al. (2020) · Nature · doi:10.1038/s41586-019-1879-7 · Cited by 697
Bock, C., Datlinger, P., Chardon, F., Coelho, M. A., Dong, M. B., Lawson, K. A., Lu, T., Maroc, L., Norman, T. M., Song, B., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-021-00093-4 · Cited by 571
Mitochondrial dysfunction and mitophagy in parkinson’s disease: from mechanism to therapy
Malpartida, A. B., Williamson, M., Narendra, D. P., Wade-Martins, R., & Ryan, B. J. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.11.007 · Cited by 482
A new era in functional genomics screens
Przybyla, L., & Gilbert, L. A. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00409-w · Cited by 281
Mitochondrial quality control in health and in Parkinson’s disease
Eldeeb, M. A., Thomas, R. A., Ragheb, M. A., Fallahi, A., & Fon, E. A. (2022) · Physiological Reviews · doi:10.1152/physrev.00041.2021 · Cited by 265
Metadata
- Authors
- Potting, C., Crochemore, C., Moretti, F., Nigsch, F., Schmidt, I., Manneville, C., Carbone, W., Knehr, J., DeJesus, R., Lindeman, A., Maher, R., Russ, C., McAllister, G., Reece-Hoyes, J. S., Hoffman, G. R., Roma, G., Müller, M., Sailer, A. W., & Helliwell, S. B.
- Affiliations
- Novartis (Switzerland) (CH)
- Novartis Institutes for BioMedical Research, Cambridge, MA 02139
- Novartis Institutes for BioMedical Research, Basel CH 4002, Switzerland;
- Corresponding author
- Helliwell, Stephen B.
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2017-12-21
- Volume
- 115
- Issue
- 2
- Pages
- E180-E189
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5777035
- OpenAlex
- W2776435687
- Cited by
- 93
- References
- 63
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 8 · 2023: 10 · 2022: 8 · 2021: 13 · 2020: 20 · 2019: 19 · 2018: 2
- FWCI
- 8.78
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-08-27)
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkin, mitophagy, transcriptional repression, Parkinson's disease, mitochondrial damage, autophagy signaling, gene expression regulation, neurons, CRISPR screen
- MeSH terms
- PTEN-Induced Putative Kinase, Cells, Cultured, Gene Expression Regulation, Humans, Infant, Newborn, Neurons, Phosphorylation, Protein Kinases, Repressor Proteins, Genome, Human, Ubiquitin, Ubiquitin-Protein Ligases, HCT116 Cells, Cell Line, Tumor, Induced Pluripotent Stem Cells, HEK293 Cells, Mitophagy, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genome-wide CRISPR screen for PARKIN regulators reveals transcriptional repression as a determinant of mitophagy. https://app.cochat.ai/papers/10.1073/pnas.1711023115
- The paper
- Potting, C., Crochemore, C., Moretti, F., Nigsch, F., Schmidt, I., Manneville, C., Carbone, W., Knehr, J., DeJesus, R., Lindeman, A., Maher, R., Russ, C., McAllister, G., Reece-Hoyes, J. S., Hoffman, G. R., Roma, G., Müller, M., Sailer, A. W., & Helliwell, S. B. (2018). Genome-wide CRISPR screen for PARKIN regulators reveals transcriptional repression as a determinant of mitophagy. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1711023115
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.